Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail?
- PMID: 18379260
- DOI: 10.1097/CCM.0b013e318168ea3e
Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail?
Abstract
Objectives: To determine how many multicenter, randomized controlled trials have been published that assess mortality as a primary outcome in the adult intensive care unit population, and to evaluate their methodologic quality.
Data source: A sensitive search strategy for randomized controlled trials was conducted in the Cochrane Central Register of Controlled Trials and in MedLine using the PubMed interface.
Study selection: All publications of adult, multicenter randomized controlled trials carried out in the intensive care unit, with mortality as a primary outcome, and including >50 patients were selected.
Data extraction: Seventy-two randomized controlled trials were retrieved and were classified according to their effect on mortality: beneficial, detrimental, or neutral.
Data synthesis: Ten of the studies reported a positive impact of the studied intervention on mortality, seven studies reported a detrimental effect of the intervention, and 55 studies showed no effect on mortality.
Conclusions: This literature search demonstrates that relatively few of the randomized controlled trials conducted in intensive care units and using mortality as a primary outcome show a beneficial impact of the intervention on the survival of critically ill patients. Methodological limitations of some of the randomized controlled trials may have prevented positive results. Other forms of evidence and end points other than mortality need to be considered when evaluating interventions in critically ill patients.
Comment in
-
The randomized controlled trial needs critical care.Crit Care Med. 2008 Nov;36(11):3118-9; author reply 3119. doi: 10.1097/CCM.0b013e31818bdd15. Crit Care Med. 2008. PMID: 18941323 No abstract available.
Similar articles
-
Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.Crit Care Med. 2006 Apr;34(4):1216-24. doi: 10.1097/01.CCM.0000208357.05675.C3. Crit Care Med. 2006. PMID: 16484923
-
We should abandon randomized controlled trials in the intensive care unit.Crit Care Med. 2010 Oct;38(10 Suppl):S534-8. doi: 10.1097/CCM.0b013e3181f208ac. Crit Care Med. 2010. PMID: 21164394
-
The number, content, and quality of randomized controlled trials in the prevention and care of injuries.J Trauma. 2008 Dec;65(6):1488-93. doi: 10.1097/TA.0b013e3181568cfc. J Trauma. 2008. PMID: 19077647 Review.
-
Glucose control in the intensive care unit.Crit Care Med. 2009 May;37(5):1769-76. doi: 10.1097/CCM.0b013e3181a19ceb. Crit Care Med. 2009. PMID: 19325461 Review.
-
Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.Ann Emerg Med. 2008 Dec;52(6):665-76. doi: 10.1016/j.annemergmed.2008.08.033. Ann Emerg Med. 2008. PMID: 19027496 Review.
Cited by
-
Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities.BMC Med Res Methodol. 2021 Feb 26;21(1):42. doi: 10.1186/s12874-021-01233-w. BMC Med Res Methodol. 2021. PMID: 33637044 Free PMC article.
-
Thirty years of critical care medicine.Crit Care. 2010;14(3):311. doi: 10.1186/cc8979. Crit Care. 2010. PMID: 20550727 Free PMC article.
-
Clinical review: Thinking outside the box--an iconoclastic view of current practice.Crit Care. 2011 Jul 26;15(4):225. doi: 10.1186/cc10245. Crit Care. 2011. PMID: 21888690 Free PMC article. Review.
-
Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them.Biomed Eng Online. 2018 Feb 20;17(1):24. doi: 10.1186/s12938-018-0455-y. Biomed Eng Online. 2018. PMID: 29463246 Free PMC article. Review.
-
Research priorities in neurocritical care.Neurocrit Care. 2012 Feb;16(1):35-41. doi: 10.1007/s12028-011-9611-y. Neurocrit Care. 2012. PMID: 21792752
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources